KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Receivables: 2012-2024

Historic Change in Receivables for Acadia Pharmaceuticals (ACAD) over the last 13 years, with Dec 2024 value amounting to $1.9 million.

  • Acadia Pharmaceuticals' Change in Receivables rose 235.61% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 15.57%. This contributed to the annual value of $1.9 million for FY2024, which is 94.81% down from last year.
  • As of FY2024, Acadia Pharmaceuticals' Change in Receivables stood at $1.9 million, which was down 94.81% from $36.1 million recorded in FY2023.
  • In the past 5 years, Acadia Pharmaceuticals' Change in Receivables registered a high of $36.1 million during FY2023, and its lowest value of -$2.2 million during FY2022.
  • Over the past 3 years, Acadia Pharmaceuticals' median Change in Receivables value was $1.9 million (recorded in 2024), while the average stood at $11.9 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 113.47% in 2022, then spiked by 1,761.54% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Change in Receivables (Yearly) stood at $12.5 million in 2020, then rose by 29.30% to $16.1 million in 2021, then plummeted by 113.47% to -$2.2 million in 2022, then spiked by 1,761.54% to $36.1 million in 2023, then crashed by 94.81% to $1.9 million in 2024.